Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Carrier

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2016
S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failureKonstantina Stathopoulou, Ilka Wittig, Juliana Heidler, et al.
European Heart Journal|December 14, 2024
Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular GenomicsPerry Elliott, Heribert Schunkert, Antoine Bondue, et al.
Journal of Molecular and Cellular Cardiology|December 16, 2010
Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardiumNicky M Boontje, Daphne Merkus, Ruud Zaremba, et al.
Journal of Molecular and Cellular Cardiology|December 7, 2018
Mechanistic role of the CREB-regulated transcription coactivator 1 in cardiac hypertrophyKaroline Morhenn, Thomas Quentin, Helen Wichmann, et al.
Circulation. Heart Failure|October 8, 2009
Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodelingDirk J Duncker, Nicky M Boontje, Daphne Merkus, et al.
Plos One|November 13, 2012
Impact of AT2 receptor deficiency on postnatal cardiovascular developmentDaniel Biermann, Andreas Heilmann, Michael Didié, et al.
European Heart Journal|May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathyDiogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Journal of Cardiovascular Development and Disease|January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve AbnormalitiesDaniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Basic Research in Cardiology|November 1, 2014
FHL2 expression and variants in hypertrophic cardiomyopathyFelix W Friedrich, Silke Reischmann, Aileen Schwalm, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart functionNiels Pietsch, Christina Yingxian Chen, Svenja Kupsch, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2016
S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failureKonstantina Stathopoulou, Ilka Wittig, Juliana Heidler, et al.
European Heart Journal|December 14, 2024
Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular GenomicsPerry Elliott, Heribert Schunkert, Antoine Bondue, et al.
Journal of Molecular and Cellular Cardiology|December 16, 2010
Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardiumNicky M Boontje, Daphne Merkus, Ruud Zaremba, et al.
Journal of Molecular and Cellular Cardiology|December 7, 2018
Mechanistic role of the CREB-regulated transcription coactivator 1 in cardiac hypertrophyKaroline Morhenn, Thomas Quentin, Helen Wichmann, et al.
Circulation. Heart Failure|October 8, 2009
Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodelingDirk J Duncker, Nicky M Boontje, Daphne Merkus, et al.
Plos One|November 13, 2012
Impact of AT2 receptor deficiency on postnatal cardiovascular developmentDaniel Biermann, Andreas Heilmann, Michael Didié, et al.
European Heart Journal|May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathyDiogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Journal of Cardiovascular Development and Disease|January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve AbnormalitiesDaniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Basic Research in Cardiology|November 1, 2014
FHL2 expression and variants in hypertrophic cardiomyopathyFelix W Friedrich, Silke Reischmann, Aileen Schwalm, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart functionNiels Pietsch, Christina Yingxian Chen, Svenja Kupsch, et al.
Pageof 15